Enrolling By Invitation OBSERVATIONAL NCT06330324

Reproductive Options in Inherited Skin Diseases (REPRO-ISD)

Reproductive Options in Inherited Skin Diseases: an International Observational Cohort Study

Sponsor: Maastricht University Medical Center

Conditions Albinism Basal Cell Nevus Syndrome Birt-Hogg-Dube Syndrome Cutis Laxa Ectodermal Dysplasia Epidermolysis Bullosa Ichthyosis Palmoplantar Keratoses Tuberous Sclerosis Xeroderma Pigmentosum

Updated 4 times since 2024 Last updated: May 16, 2025 Started: Jan 1, 2024 Primary completion: Sep 1, 2026 Completion: Sep 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Albinism and Basal Cell Nevus Syndrome and is currently ongoing. Maastricht University Medical Center leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Jun 2025 — Present [monthly]

Enrolling By Invitation
Sep 2024 — Jun 2025 [monthly]

Enrolling By Invitation
Jul 2024 — Sep 2024 [monthly]

Enrolling By Invitation
Apr 2024 — Jul 2024 [monthly]

Enrolling By Invitation

First recorded

Jan 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maastricht University Medical Center

Data source: Maastricht University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maastricht, Netherlands